Dose Intensification in Hormone Receptor–Negative and/or Human Epidermal Growth Factor Receptor 2–Negative High-Risk Primary Breast Cancer Authors retain all rights in any data supplements associated ...
Leading cancer experts at the University of Birmingham have solved a long-standing question of how various types of mutations in just one gene cause different types of diseases. A team of scientists ...
Circulating Tumor DNA as a Prognostic Biomarker for Recurrence in Patients With Locoregional Esophagogastric Cancers With a Pathologic Complete Response PD-1 inhibition is effective in patients with ...
A groundbreaking study published in this week’s issue of PNAS by scientists from Israel and Ghana shows that an evolutionarily significant mutation in the human APOL1 gene arises not randomly but more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results